The impact of post-remission therapy on outcome of patients with poor-risk AIDS and secondary AML treated with intensive chemotherapy with or without stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAK, HOVON, Scandinavian, and the Gimema leukemia groups

De Witte, TM; Hagemeijer, A; Suciu, S; Belhabri, A; Delforge, Michel; Aul, C; Avaido, M; Selleslag, D; Schouten, H; Biersack, H; Ferrant, A; Kovacsovics, T; Muus, P; Jansen, J; Beeldens, F; Gratwohl, A; Hess, U; Helstrom-Lindberg, E; Wijermans, P; Ossenkoppele, G; Marie, JP; Willemze, R; Amadori, S

Blood

The impact of post-remission therapy on outcome of patients with poor-risk AIDS and secondary AML treated with intensive chemotherapy with or without stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAK, HOVON, Scandinavian, and the Gimema leukemia groups

Author:

De Witte, TM

Hagemeijer, A ; Suciu, S ; Belhabri, A ; Delforge, Michel ; Aul, C ; Avaido, M ; Selleslag, D ; Schouten, H ; Biersack, H ; Ferrant, A ; Kovacsovics, T ; Muus, P ; Jansen, J ; Beeldens, F ; Gratwohl, A ; Hess, U ; Helstrom-Lindberg, E ; Wijermans, P ; Ossenkoppele, G ; Marie, JP ; Willemze, R ; Amadori, S

Keywords:

1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, Immunology

Blood The impact of post-remission therapy on outcome of patients with poor-risk AIDS and secondary AML treated with intensive chemotherapy with or without stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAK, HOVON, Scandinavian, and the Gimema leukemia groups

Author:

Keywords:

Blood

The impact of post-remission therapy on outcome of patients with poor-risk AIDS and secondary AML treated with intensive chemotherapy with or without stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAK, HOVON, Scandinavian, and the Gimema leukemia groups